Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPAR<i>δ</i>‐AMPK‐PGC‐1<i>α</i> Pathway in Dyslipidemic Conditions
Yoon-Mi Han(Korea University Medical Center), Ji Hoon Jeong(Soonchunhyang University)
Cited by 41
Related Papers
METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice
|Experimental & Molecular Medicine|2018|178
Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression
|Journal of Pharmacology and Experimental Therapeutics|2018|40
Protectin DX ameliorates palmitate- or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in mice
|Scientific Reports|2017|38
Protectin DX attenuates LPS-induced inflammation and insulin resistance in adipocytes via AMPK-mediated suppression of the NF-κB pathway
|American Journal of Physiology-Endocrinology and Metabolism|2018|33
The inhibitory effect of vitexin on the agonist-induced regulation of vascular contractility
|Die Pharmazie|2014|29